Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 21802-37-9 Chemical Structure| 21802-37-9

Structure of Caerulomycin A
CAS No.: 21802-37-9

Chemical Structure| 21802-37-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Caerulomycin A is a rare and unusual antibiotic containing a core 2, 2'-bispyridyl with an oxime substituent, isolated and purified from a strain of Streptomyces caeruleus.

Synonyms: Caerulomycin; Cerulomycin; HE185727

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Caerulomycin A

CAS No. :21802-37-9
Formula : C12H11N3O2
M.W : 229.23
SMILES Code : COC1=CC(C2=NC=CC=C2)=NC(/C=N/O)=C1
Synonyms :
Caerulomycin; Cerulomycin; HE185727
MDL No. :MFCD03093715

Safety of Caerulomycin A

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H228-H301-H315-H319-H335-H372
Precautionary Statements:P280-P210-P240-P264-P270-P301+P310-P330-P370+P378-P403+P233-P405-P501
Class:4.1(6.1)
UN#:2926
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
RAW264.7 macrophages 20 μM 6 h Inhibited LPS-induced M1-type macrophage polarization, reduced the expression of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), and increased the expression of anti-inflammatory cytokines (IL-4, IL-10) Eur J Med Res. 2025 Jan 10;30(1):22
CD4+ T cells 0–0.15 μM 5 days CaeA significantly up-regulated the frequency of Tregs, as evidenced by an increased frequency of CD4+Foxp3+ cells, and suppressed the number of Th1 and Th17 cells. J Biol Chem. 2014 Jun 20;289(25):17515-28

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice LPS-induced sepsis model Intraperitoneal injection 20 mg/kg Single dose, observed for 12 hours Increased the survival rate of septic mice, reduced the expression of M1-type macrophage markers (CD86 and NOS2) and pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), and increased the expression of M2-type markers (CD206 and ARG1) and anti-inflammatory cytokines (IL-4 and IL-10) Eur J Med Res. 2025 Jan 10;30(1):22
SD rats Intestinal flora model in SD rats Intragastric administration 5 mg/kg For 2, 3 and 4 weeks Caerulomycin A influenced the diversity of intestinal flora in SD rats, increasing the abundance of beneficial bacteria such as Prevotella_1, Prevotellaceae_UCG-001, and Lactobacillus, and decreasing the abundance of harmful bacteria such as Alloprevotella and Ruminiclostridium_1. Mar Drugs. 2020 May 22;18(5):277

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.36mL

0.87mL

0.44mL

21.81mL

4.36mL

2.18mL

43.62mL

8.72mL

4.36mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories